Alamar Biosciences Balance Sheet
NASDAQ: ALMRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Alamar Biosciences has no annual balance sheet on file yet, so quarterly figures are shown instead.
Alamar Biosciences financial position
As of Jun 30, 2026, Alamar Biosciences reported total assets of $391.0 million against total liabilities of $78.1 million. Shareholders' equity stood at $312.9 million, or 80.0% of assets. The company held $133.0 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 11.85, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Alamar Biosciences balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Cash & Equivalents | 132.97M | 64.59M | — | — |
| Short-Term Investments | 117.08M | 0 | — | — |
| Receivables | 20.34M | 19.52M | — | — |
| Inventory | 45.41M | 39.93M | — | — |
| Total Current Assets | 331.38M | 141.47M | — | — |
| Property, Plant & Equipment | 13.36M | 10.47M | — | — |
| Long-Term Investments | — | 0 | — | — |
| Total Assets | 390.98M | 186.45M | — | — |
| Accounts Payable | 13.79M | 5.63M | — | — |
| Total Current Liabilities | 27.96M | 24.05M | — | — |
| Total Liabilities | 78.12M | 129.53M | — | — |
| Shareholders' Equity | 312.86M | -178.07M | -146.61M | -140.29M |
| Retained Earnings | -203.30M | -190.10M | — | — |
| Net Cash (Debt) | 250.05M | 64.59M | — | — |
This table shows 4 quarterly periods of Alamar Biosciences's balance sheet, from Q2 2026 back to Q? 2025, across 14 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ALMR's reporting calendar. What is a balance sheet?